UMBFP Rule 144 Notice: Insider Plans to Sell 1,500 Shares on 08/22/2025
Rhea-AI Filing Summary
Form 144 notice for UMB Financial (UMBFP) records a proposed sale of common stock under Rule 144. The filer plans to sell 1,500 common shares through Merrill on 08/22/2025 with an aggregate market value of $178,315.00. The filing shows 75,928,255 shares outstanding, and the 1,500 shares represent approximately 0.002% of outstanding common stock. The securities to be sold were acquired through restricted stock vesting in January and February 2025 (multiple vesting dates totaling the reported units). The filer certifies there are no undisclosed material adverse facts and reports no securities sold in the past three months for the account. The notice includes broker information and acquisition dates for each vested grant.
Positive
- Transparent disclosure of proposed sale including broker, sale date, and aggregate market value
- Acquisition method clearly stated as restricted stock vesting with specific vesting dates and units
- Small size relative to outstanding shares (~0.002% of 75,928,255 outstanding), suggesting limited market impact
Negative
- None.
Insights
TL;DR: Small-rule-144 sale disclosed; not material to capitalization but useful for transparency.
The filing documents a proposed sale of 1,500 shares valued at $178,315 executed through Merrill on 08/22/2025. The shares were acquired via restricted stock vesting across January and February 2025. Relative to the 75,928,255 shares outstanding, this sale is immaterial to market capitalization and should have limited market impact. The disclosure meets Rule 144 notice requirements by listing acquisition dates, acquisition method, broker, and that no sales occurred in the prior three months.
TL;DR: Procedurally compliant filing with required attestations; no red flags in the provided data.
The notice includes the required representations, broker details, acquisition history showing restricted stock vesting, and a statement that the signer is unaware of undisclosed material adverse information. There are no entries for securities sold during the past three months. From a compliance perspective, the form contains the expected elements for a Rule 144 sale notice and does not present any explicit procedural deficiencies within the supplied content.